| Clinical data | |
|---|---|
| Trade names | Averbol, Dianabol, Danabol, Metanabol, Naposim, Vetanabol |
| Pregnancy category |
|
| Routes of administration |
Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Biological half-life | 4.5–6 hours |
| Excretion | Renal |
| Identifiers | |
|
|
| Synonyms | Methandienone; Methandrostenolone; Methandrolone; Dehydromethyltestosterone; Methylboldenone; NSC-51180; NSC-42722; 17α-Methyl-δ1-testosterone; 17α-Methylandrost-1,4-dien-17β-ol-3-one |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| ECHA InfoCard | 100.000.716 |
| Chemical and physical data | |
| Formula | C20H28O2 |
| Molar mass | 300.441 g/mol |
| 3D model (Jmol) | |
|
|
|
|
|
|
|
Metandienone (INN) (brand names Averbol, Dianabol, Danabol, Metanabol, Naposim, Vetanabol), or methandienone (BAN), also known as methandrostenolone, as well as 17α-methyl-δ1-testosterone or as 17α-methylandrost-1,4-dien-17β-ol-3-one, is an orally active, synthetic anabolic-androgenic steroid (AAS) and a 17α-methylated derivative of testosterone (specifically, the 17α-methylated derivative of boldenone (Δ1-testosterone)).
Metandienone was originally developed in 1957 by CIBA and marketed in Germany and the United States. As the CIBA product Dianabol, metandienone quickly became the first widely used anabolic-androgenic steroid among professional and amateur athletes, and remains the most common orally-administered steroid for non-medical use.
It is currently a controlled substance in the U.S. and UK and remains popular among bodybuilders. Metandienone is readily available without a prescription in certain countries such as Mexico (under the brand name Reforvit-b), and is also manufactured in Asia and many Eastern European countries.
Metandienone was first synthesized in 1956 by researchers at the CIBA laboratories in Basel, Switzerland. CIBA filed for a US patent in 1957, and began marketing the compound as Dianabol in 1958.